Am. Carter et al., GENDER-SPECIFIC ASSOCIATIONS OF THE FIBRINOGEN B-BETA-448 POLYMORPHISM, FIBRINOGEN LEVELS, AND ACUTE CEREBROVASCULAR-DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 589-594
Fibrinogen is an independent risk factor for the development of stroke
. Factors influencing circulating levels of fibrinogen include age, sm
oking, gender, and genetic factors. The aim of this study was to deter
mine the relationship between a polymorphism at position 448 of the B
beta fibrinogen gene, fibrinogen levels, gender, and the risk of strok
e. Fibrinogen levels were determined in 305 patients with stroke, take
n within 10 days of the acute event and 3 months later, and in 197 con
trol subjects. Initial fibrinogen levels in patients (4.49 g/L) were s
ignificantly higher than at 3 months (3.85 g/L, P<.0001), consistent w
ith resolution of the acute-phase response. At 3 months, levels were o
nly significantly higher than for control subjects in the male patient
s (3.86 g/L versus 3.31 g/L, P<.0001). Fibrinogen levels were associat
ed with B beta 448 genotype in male patients at 3 months (1/1=3.62 g/L
, 1/2+2/2=4.27 g/L, P=.01). There was a significant difference in the
genotype distribution in female patients and control subjects (patient
s: 1/1=95, 1/2=34, 2/2=6; control subjects: 1/1=61, 1/2=50, 2/2=3, P=.
008). These data suggest that the mechanisms linking fibrinogen and th
e development of cerebrovascular disease are different in males and fe
males. In male patients, the increase in fibrinogen levels may be infl
uenced by environmental factors, while in females there may be a funct
ional difference in the fibrinogen molecule unrelated to fibrinogen le
vels.